Clincosm LogoSign in Get a demo

Hepatocellular Carcinoma

Showing 26 - 50 of 1,472
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma, Chemo Effect, Chemotherapeutic Toxicity Trial in Guangzhou (Oxaliplatin,calcium folinic acid,

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU
  • +4 more
  • Guangzhou, Guangdong, China
    SUN Yat-sen University Cancer Center
Sep 11, 2023

Hepatocellular Carcinoma Trial in New Delhi (N Acetylcysteine, Dexamethasone, Placebo)

Not yet recruiting
  • Hepatocellular Carcinoma
  • N Acetylcysteine
  • +2 more
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences
Sep 8, 2023

Deep Learning Image Reconstruction for Abdominal CT of

Recruiting
  • Hepatocellular Carcinoma
    • Nancy, France
      CHRU de Nancy
    Sep 13, 2023

    Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Melanoma Trial in United States (MT-8421, Nivolumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • +10 more
    • Los Angeles, California
    • +4 more
    Sep 5, 2023

    Hepatocellular Carcinoma Trial in Taoyuan (ADI-PEG20)

    Recruiting
    • Hepatocellular Carcinoma
    • Taoyuan, Taiwan
      Chang Gung Memorial Hospital, Linkou branch
    Sep 6, 2023

    Hepatocellular Carcinoma Trial in Shanghai (Anlotinib and TQB2450)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Anlotinib and TQB2450
    • Shanghai, Shanghai, China
      Zhongshan hospital
    Sep 4, 2023

    Hepatocellular Carcinoma Trial in Mansoura (Sorafenib Tablets)

    Recruiting
    • Hepatocellular Carcinoma
    • Sorafenib Tablets
    • Mansoura, El-Dakahelia, Egypt
      Mansoura University Hospital
    Sep 3, 2023

    Hepatocellular Carcinoma Trial in Guangzhou (Sintilimab)

    Recruiting
    • Hepatocellular Carcinoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 4, 2023

    Interpretable Deep Learning Framework for Post-Hepatectomy Liver

    Not yet recruiting
    • Post-hepatectomy Liver Failure
    • +2 more
    • The explanation of deep learning framework (VAE-MLP) , including counterfactual explanations and layerwise relevance propagation
    • +2 more
    • Guangzhou, Guangdong, China
      The First Affiliated Hospital of Sun Yat-Sen University
    Sep 4, 2023

    Hepatocellular Carcinoma Trial in Yichang (Sintilimab)

    Recruiting
    • Hepatocellular Carcinoma
    • Yichang, Hubei, China
      Department of Medical Oncology, Central Hospital of Yichang City
    Sep 1, 2023

    Hepatocellular Carcinoma Trial in China (E-TACE)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • E-TACE
    • Kaifeng, Henan, China
    • +26 more
    Sep 4, 2023

    17-009: Multi-Institutional Study Examining HCC Undergoing Liver

    Active, not recruiting
    • Hepatocellular Carcinoma
      • Cleveland, Ohio
      • +1 more
      Aug 29, 2023

      Advanced Solid Tumor, Hepatocellular Carcinoma Trial in Los Angeles (TORL-4-500)

      Not yet recruiting
      • Advanced Solid Tumor
      • Hepatocellular Carcinoma
      • Los Angeles, California
        UCLA - JCCC Clinical Research Unit
      Aug 23, 2023

      Hepatocellular Carcinoma, Cirrhosis Trial in Falls Church (Namenda)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • Cirrhosis
      • Falls Church, Virginia
        Inova Health Care Service
      Aug 18, 2023

      HCC With Portal Vein Tumor Thrombosis on Basis of Risk Scoring

      Completed
      • Hepatocellular Carcinoma
      • +2 more
        • Daegu, DalSeo-gu, Korea, Republic of
          Keimyung university Dongsan Medical Center
        Aug 16, 2023

        Thrombocytopenia, Hepatocellular Carcinoma Trial in Guangzhou (Avatrombopag)

        Not yet recruiting
        • Thrombocytopenia
        • Hepatocellular Carcinoma
        • Guangzhou, Guangdong, China
          The Second Affiliated Hospital of Guangzhou Medical University
        Aug 17, 2023

        Hepatocellular Carcinoma Trial in Guangzhou (SIRT)

        Not yet recruiting
        • Hepatocellular Carcinoma
        • SIRT
        • Guangzhou, Guangdong, China
          The Second Affiliated Hospital of Guangzhou Medical University
        Aug 9, 2023

        Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatocellular Carcinoma Non-resectable Trial in Seoul (Atezolizumab plus

        Recruiting
        • Hepatocellular Carcinoma
        • +4 more
        • Atezolizumab plus bevacizumab, combined EBRT to vascular invasion
        • Atezolizumab plus bevacizumab
        • Seoul, Korea, Republic of
          Asan Medical Center
        Aug 7, 2023

        Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, sintilimab plus SIRT)

        Not yet recruiting
        • Hepatocellular Carcinoma
        • Lenvatinib, sintilimab plus SIRT
        • Guangzhou, Guangdong, China
          The Second Affiliated Hospital of Guangzhou Medical University
        Aug 8, 2023

        Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor Thrombus Trial (I-125 Seeds Brachytherapy in PVTT,

        Not yet recruiting
        • Hepatocellular Carcinoma
        • +2 more
        • I-125 Seeds Brachytherapy in PVTT
        • +2 more
        • (no location specified)
        Aug 14, 2023

        Hepatocellular Carcinoma Trial in Roma (multimodal ultrasound)

        Recruiting
        • Hepatocellular Carcinoma
        • multimodal ultrasound
        • Roma, Italy
          Fondazione Policlinico Gemelli IRCCS
        Aug 3, 2023

        Liver Cirrhosis, Hepatocellular Carcinoma Trial (Elecsys® GAAD)

        Not yet recruiting
        • Liver Cirrhosis
        • Hepatocellular Carcinoma
        • Elecsys® GAAD
        • (no location specified)
        Aug 4, 2023

        Hepatocellular Carcinoma Trial in Nanjing, Shanghai (QL1706, Bevacizumab, Oxaliplatin injection)

        Not yet recruiting
        • Hepatocellular Carcinoma
        • Nanjing, Jiangsu, China
        • +1 more
        Jul 28, 2023

        Hepatocellular Carcinoma Trial in Tianjin (HAIC, Adebrelimab, Bevacizumab)

        Not yet recruiting
        • Hepatocellular Carcinoma
        • HAIC
        • +2 more
        • Tianjin, Tianjin, China
          Tianjin Cancer Hospital Airport Hospital
        Jul 27, 2023

        Postoperative Outcomes in Chinese HCC Patients Treated With

        Recruiting
        • Hepatocellular Carcinoma
          • Shanghai, Shanghai, China
            Zhongshan Hospital, Fudan University
          Aug 1, 2023